<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02931877</url>
  </required_header>
  <id_info>
    <org_study_id>Li Hong-Group</org_study_id>
    <nct_id>NCT02931877</nct_id>
  </id_info>
  <brief_title>Comparison of Postoperative Outcome After Sevoflurane and Propofol Anaesthesia</brief_title>
  <official_title>Comparison of Postoperative Outcome and Cognitive Function After Sevoflurane and Propofol Anaesthesia for Cardiac Valvular Surgery With Cardiopulmonary Bypass</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Xinqiao Hospital of Chongqing</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Xinqiao Hospital of Chongqing</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      As the investigators know, postoperative cognitive dysfunction (POCD) is a fairly
      well-documented clinical phenomenon, which affect patients' short-term and long-term outcome.
      Most patients will receive general anesthesia and cardiopulmonary bypass (CPB) during cardiac
      valvular surgery. Inhalation sevoflurane based and propofol based anesthesia are most
      commonly used strategy for general anesthesia. At present, it was unknown that which one is
      better in providing cerebral protection effect for patients undergoing cardiac valvular
      surgery with CPB. The current study aimed to explore the possible difference.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The investigators hypothesize that the incidence of postoperative cognitive dysfunction
      (POCD) is not different in patients received intravenous anesthetics propofol or sevoflurane
      for their cardiac valvular surgery. Two groups of general anesthetics (propofol or
      sevoflurane) are used to explore the possible difference of the postoperative outcome and the
      incidence of POCD. After cardiac valvular surgery with CPB, patients' POCD tests at 7 days
      after the surgery, and postoperative delirium, etc., are evaluated by different
      questionnaires. Also the blood sample of these patients are collected for detection of some
      stress hormones.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>October 2016</start_date>
  <completion_date type="Anticipated">June 2018</completion_date>
  <primary_completion_date type="Anticipated">May 2018</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of patients with postoperative cognitive dysfunction (POCD)</measure>
    <time_frame>From 7 days after the surgery to the day of discharge from hospital</time_frame>
    <description>POCD is a composite outcome measure</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Postoperative delirium (POD)</measure>
    <time_frame>Up to 7 days after the surgery</time_frame>
    <description>POD is evaluated by a commonly used questionnaire</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Degree of increase of stress hormones</measure>
    <time_frame>Up to 24 hours after the surgery</time_frame>
    <description>Stress hormones include S-100β, Il-6, etc.</description>
  </other_outcome>
  <other_outcome>
    <measure>Length of ICU stay</measure>
    <time_frame>Up to 7 days after the surgery</time_frame>
    <description>The time for patient stay in ICU</description>
  </other_outcome>
  <other_outcome>
    <measure>Length of hospital stay</measure>
    <time_frame>Up to 3 months after the surgery</time_frame>
    <description>The time for patient stay in hospital</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Postoperative Cognitive Dysfunction</condition>
  <arm_group>
    <arm_group_label>Sevoflurane</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Maintenance of anesthesia with sevoflurane during the cardiac valvular surgery.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Propofol</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Maintenance of anesthesia propofol during the cardiac valvular surgery.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>sevoflurane</intervention_name>
    <arm_group_label>Sevoflurane</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>propofol</intervention_name>
    <arm_group_label>Propofol</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients who receive cardiac valvular surgery

          -  18 to 65 years

          -  American society of anesthesiologists classification Ⅱto Ⅲ

          -  education level higher than elementary school

        Exclusion Criteria:

          -  Patients are not expected to be alive for longer than 3 months.

          -  Mini-mental State Examination (MMSE) score ≤ 23.

          -  current use of sedatives or antidepressant

          -  history of dementia, psychiatric illness or any diseases of central nervous system.

          -  accompanying liver or kidney function deficiency

          -  history of some endocrine disease

          -  alcoholism and drug dependence

          -  patients previously included in this study or currently included in the other clinical
             study

          -  patients who have second surgery during the study period

          -  difficult to follow up or patients with poor compliance
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hong Li, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Anesthesiology, Xinqiao Hospital, Third Military Medical University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Guangyou Duan, M.D.</last_name>
    <phone>(+86)18323376014</phone>
    <email>472217836@qq.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Xinan Hospital, Third Military Medical University</name>
      <address>
        <city>Chongqing</city>
        <state>Chongqing</state>
        <zip>400037</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Kaizhi Lu, M.D.</last_name>
      <phone>(+86)13608380096</phone>
      <email>ukaizhi@163.net</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Xinqiao Hospital, Third Military Medical University</name>
      <address>
        <city>Chongqing</city>
        <state>Chongqing</state>
        <zip>400037</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Feng Chen, M.D.</last_name>
      <phone>(+86)15215168625</phone>
      <email>867484473@qq.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Daping Hospital, Third Military Medical University</name>
      <address>
        <city>Chongqing</city>
        <state>Chongqing</state>
        <zip>400042</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Liyong Chen, M.D.</last_name>
      <phone>(+86)13228687367</phone>
      <email>mzkcly@yahoo.com.cn</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>November 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 10, 2016</study_first_submitted>
  <study_first_submitted_qc>October 12, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 13, 2016</study_first_posted>
  <last_update_submitted>November 27, 2017</last_update_submitted>
  <last_update_submitted_qc>November 27, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">November 28, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Xinqiao Hospital of Chongqing</investigator_affiliation>
    <investigator_full_name>Hong Li</investigator_full_name>
    <investigator_title>Director, Department of Anesthesiology</investigator_title>
  </responsible_party>
  <keyword>Sevoflurane</keyword>
  <keyword>Propofol</keyword>
  <keyword>Cardiac valvular surgery</keyword>
  <keyword>Cardiopulmonary bypass</keyword>
  <keyword>Postoperative cognitive dysfunction</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cognitive Dysfunction</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anesthetics</mesh_term>
    <mesh_term>Propofol</mesh_term>
    <mesh_term>Sevoflurane</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

